Lung Cancer Screening Improves Stage I Detection, Reduces Stage IV Cases
Implementing lung cancer screening at four diverse healthcare systems resulted in a 6.6% decrease in Stage IV disease.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
Latest
Blood Test Helps Identify Who Needs Lung Cancer Assessment
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Lung Cancer
Latest
Thermo Fisher’s Oncomine Dx Receives FDA Premarket Approval
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic.
Spectrum Solutions, UCLA Collaborate on Saliva-Based NGS Liquid Biopsy Research for Early Detection of Lung Cancer
Study to focus on using saliva in the analysis of cell-free circulating tumor DNA to accurately and noninvasively detect non-small cell lung cancer.
Read More
BioAffinity Automated Flow Cytometry Test Detects Lung Cancer in Sputum
The test validation trial resulted in CyPath Lung specificity of 88% and sensitivity of 82%, similar to far more invasive procedures currently used to diagnose lung cancer.
Read More
FDA Approves First CDx for Expanded EGFR TKI Therapies in NSCLC Patients
The group claim will also enable the test to be used as a CDx for any future approved EGFR TKI therapies targeting the same mutations.
Read More
FDA Approves New FoundationOne Liquid CDx Companion Diagnostic Indications for 3 Cancer Therapies
FDA approved FoundationOne Liquid CDx for three new companion diagnostic indications: Piqray in advanced or metastatic breast cancer; Rubraca in advanced ovarian cancer; and Alecensa in a certain type of metastatic non-small cell lung cancer.
Read More
Large Prospective Lung Cancer Study to Be Presented at ESMO
Idylla reduced EGFR mutation testing turnaround time by more than a week versus reference methods for patients with NSCLC.
Read More
FDA Approves First NGS-Based CDx for RET Fusion-Positive NSCLC
Thermo Fisher Scientific’s Oncomine Dx Target Test simultaneously evaluates 23 genes clinically associated with NSCLC.
Read More
Thermo Fisher, Hengrui Therapeutics to Develop CDx for NSCLC
The companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients with HER2 mutations.
Read More
FDA Approves First Liquid Biopsy NGS Companion Diagnostic
This is the first approval to combine two technologies—NGS and liquid biopsy—in one diagnostic in order to guide treatment decisions.
Read More
Israel Expands Non-Small Cell Lung Cancer Testing Coverage
Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.
Read MoreGuardant Health, Janssen to Develop Liquid Biopsy Companion Diagnostic
The collaborators are pursuing regulatory approval of the Guardant360 CDx as a companion diagnostic for amivantamab for the treatment of NSCLC.
Read MoreNeoGenomics and Inivata Collaborate to Commercialize InVisionFirst-Lung Liquid Biopsy Test
InVisionFirst-Lung is a ctDNA next-generation sequencing liquid biopsy assay testing 37 genes relevant to the care of advanced NSCLC patients.
Read MoreArcherDx and AstraZeneca to Develop Personalized Cancer Monitoring Assays
ArcherDx plans to leverage the personalized cancer monitoring assays to develop companion diagnostics for AstraZeneca’s associated immunooncology therapies.
Read More
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More
Interventional Study to Evaluate Multicancer Early Detection Test
The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.
Read More
Urine Test Could Offer Early Detection of Lung Tumors
A noninvasive urine test that can detect the presence of proteins linked to lung cancer could help detect more tumors in the early stages of the disease.
Read More